Everaert, Hendrik

Incidence of Thyroid-Related Adverse Events in Melanoma Patients Treated With Pembrolizumab

de Filette, J., Jansen, Y., Schreuer, M., Everaert, H., Velkeniers, B., Neyns, B., & Bravenboer, B. (2016) · The Journal of Clinical Endocrinology & Metabolism

Cancer Immunotherapy and BiomarkersThyroid Disorders and Treatments

Cited by 244

Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase I clinical trial

Duerinck, J., Schwarze, J. K., Awada, G., Tijtgat, J., Vaeyens, F., Bertels, C., Geens, W., Klein, S., Seynaeve, L., Cras, L., et al. (2021) · Journal for ImmunoTherapy of Cancer

Glioma Diagnosis and TreatmentCancer Immunotherapy and Biomarkers

Cited by 113